Dr Callum Duncan is a Consultant Neurologist at Aberdeen Royal Infirmary where he has run a Headache clinic, along with Dr David Watson (GPwSI Headache), since 2008. He obtained his MBChB from Aberdeen University in 1999, during which he also obtained an intercalated PhD. He trained in General Medicine in Aberdeen, Neurology in Aberdeen and Edinburgh, and Headache in Aberdeen, Edinburgh, Glasgow and the NHNN Queen Square London.
He is chair of the SIGN 155 guideline group which has recently updated guidance on pharmacological management of migraine (2026). He is a past secretary of the British Association for the Study of Headache (2016-2022) and chair of the development group for the Scottish National Headache and Scottish National Facial Pain Pathways (part of Scottish Government Modernising Patient Pathways initiative).
